Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana. Reports first emerged last week that the Trump administration might change marijuana from a Schedule I drug to a Schedule III drug, which would lessen restrictions on it. Cresco Labs Inc (OTCQX: CRLBF) On Monday, President Trump told reporters that he was "considering†the reclassification. "We are considering that because a lot of people want to see ...